Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/41881
Title: Coronary calcification in patients presenting with acute coronary syndromes: insights from the MATRIX trial
Authors: Sanz-Sanchez, Jorge
Garcia-Garcia, Hector M.
Branca, Mattia
Frigoli, Enrico
Leonardi, Sergio
Gagnor, Andrea
Calabro, Paolo
Garducci, Stefano
Rubartelli, Paolo
Briguori, Carlo
Ando, Giuseppe
Repetto, Alessandra
Limbruno, Ugo
Garbo, Roberto
Sganzerla, Paolo
Russo, Filippo
Lupi, Alessandro
Cortese, Bernardo
Ausiello, Arturo
Ierna, Salvatore
Esposito, Giovanni
Santarelli, Andrea
Sardella, Gennaro
Varbella, Fernando
Tresoldi, Simone
de Cesare, Nicoletta
Rigattieri, Stefano
Zingarelli, Antonio
Tosi, Paolo
van 't Hof, Arnoud
Boccuzzi, Giacomo
Omerovic, Elmir
Sabate, Manel
Heg, Dik
VRANCKX, Pascal 
Valgimigli, Marco
Issue Date: 2023
Publisher: OXFORD UNIV PRESS
Source: European Heart Journal-Acute Cardiovascular Care, 12 (11) , p. 782 -791
Abstract: Aims The role of coronary calcification on clinical outcomes among different revascularization strategies in patients presenting with acute coronary syndromes (ACSs) has been rarely investigated. The aim of this investigation is to evaluate the role of coronary calcification, detected by coronary angiography, in the whole spectrum of patients presenting with acute ACS.Methods and results The present study was a post hoc analysis of the MATRIX programme. The primary endpoint was major adverse cardiovascular events (MACE), defined as the composite of all-cause mortality, myocardial infarction (MI), or stroke up to 365 days. Among the 8404 patients randomized in the MATRIX trial, data about coronary calcification were available in 7446 (88.6%) and therefore were included in this post hoc analysis. Overall, 875 patients (11.7%) presented with severe coronary calcification, while 6571 patients (88.3%) did not present severe coronary calcification on coronary angiography. Fewer patients with severe coronary calcification underwent percutaneous coronary intervention whereas coronary artery bypass grafting or medical therapy-only was more frequent compared with patients without severe calcification. At 1-year follow-up, MACE occurred in 237 (27.1%) patients with severe calcified coronary lesions and 985 (15%) patients without severe coronary calcified lesions [hazard ratio (HR) 1.91; 95% confidence interval (CI) 1.66-2.20, P < 0.001]. All-cause mortality was 8.6% in patients presenting with and 3.7% in those without severe coronary calcification (HR 2.38, 1.84-3.09, P < 0.001). Patients with severe coronary calcification incurred higher rate of MI (20.1% vs. 11.5%, HR 1.81; 95% CI 1.53-2.1, P < 0.001) and similar rate of stroke (0.8% vs. 0.6%, HR 1.35; 95% CI 0.61-3.02, P = 0.46).Conclusion Patients with ACS and severe coronary calcification, as compared to those without, are associated with worse clinical outcomes irrespective of the management strategy.
Notes: Garcia-Garcia, HM (corresponding author), MedStar Washington Hosp Ctr, Intervent Cardiol, 10 Irving St NW, Washington, DC 20010 USA.; Valgimigli, M (corresponding author), Ente Osped Cantonale, Cardioctr Ticino Inst, Div Cardiol, Via Tesserete 48, CH-6900 Lugano, Switzerland.
hector.m.garciagarcia@medstar.net; marco.valgimigli@cardiocentro.org
Keywords: Acute coronary syndromes;Coronary calcification;Percutaneous coronary intervention;Coronary artery bypass grafting;Medical therapy
Document URI: http://hdl.handle.net/1942/41881
ISSN: 2048-8726
e-ISSN: 2048-8734
DOI: 10.1093/ehjacc/zuad122
ISI #: 001093343600001
Category: A1
Type: Journal Contribution
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
rJLCvsrM8vm537IKeQrKq0S.pdf
  Until 2024-05-31
Peer-reviewed author version1.15 MBAdobe PDFView/Open    Request a copy
Show full item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.